Pomerantz probes HCA Healthcare after guidance cut
Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash
Pomerantz LLP has opened an investigation into HCA Healthcare over potential securities fraud or unlawful business practices, after the hospital operator lowered its full-year profit guidance, citing an unfavorable payer mix. HCA Healthcare still posted an 8.70 percent rise in second-quarter revenue to USD 20.23 billion, and shares gained 1.20 percent. The company reports third-quarter results on October 27, which should clarify its financial performance and management's outlook.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.